Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Operating cash flow minus capital expenditures
| Period | Value | Change |
|---|---|---|
| 2024 | $-421.68M | +19.2% |
| 2023 | $-521.57M | +1.0% |
| 2022 | $-526.59M | -27.9% |
| 2021 | $-411.79M | -133.8% |
| 2020 | $-176.13M | +52.4% |
| 2019 | $-370.21M | -25.6% |
| 2018 | $-294.64M | -14.8% |
| 2017 | $-256.64M | -49.9% |
| 2016 | $-171.16M | -54.3% |
| 2015 | $-110.93M | - |